Cryoport Inc 주요 수익원은 Life Sciences Services이며, 최신 수익 발표에서 수익은 156,951,000입니다. 지역별로는 Americas이 Cryoport Inc의 주요 시장이며, 수익은 126,373,000입니다.
Cryoport Inc은 수익성이 있나요?
예, 최신 재무제표에 따르면 Cryoport Inc의 순이익은 $70입니다.
Cryoport Inc에 부채가 있나요?
예, Cryoport Inc의 부채는 262입니다.
Cryoport Inc의 발행 주식은 몇 주인가요?
Cryoport Inc의 총 발행 주식은 49.85주입니다.
주요 통계
이전 종가
$8.51
시가
$8.36
일일 범위
$8.3 - $8.8
52주 범위
$4.63 - $11.45
거래량
236.9K
평균 거래량
395.6K
배당수익률
--
EPS(TTM)
1.48
시가총액
$437.2M
CYRX란 무엇인가요?
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.